Hirsutella sinensis Polysaccharide Extraction for Insulin Sensitivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for type 2 diabetes mellitus, such as metformin, often produce side effects and require lifestyle changes, limiting their efficacy and patient compliance, and there is a need for alternative measures to improve insulin sensitivity without severe toxicity or adverse effects.

Innovation Solution

Administration of a polysaccharide extracted from Hirsutella sinensis, isolated from a water extract of its mycelium, which contains specific monosaccharides and has a defined molecular weight range, to improve insulin sensitivity and reduce blood glucose levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If metformin and other anti-diabetic medications are used to decrease hyperglycemia and increase insulin sensitivity, then blood glucose levels are controlled, but side effects and toxicity limit treatment efficacy and patient compliance

Engineering Contradiction:
Improvetreatment efficacyVSAvoidside effects and toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and isolates the active polysaccharide component (H. sinensis polysaccharide with specific molecular weight 312 kDa and specific monosaccharide composition) from the whole H. sinensis mycelium. This extraction principle allows obtaining the therapeutic effect while eliminating other components that may cause side effects, thus resolving the contradiction between treatment efficacy and harmful factors

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent specifies precise parameters for the polysaccharide including molecular weight (312 kDa), polydispersity index (7.475), and monosaccharide composition ratios. By controlling these parameters, the patent optimizes the therapeutic effect while minimizing side effects, resolving the contradiction between reliability and harmful factors

Inventive Principle:
Principle #35Parameter changes

2Reliability

If lifestyle changes are required to improve insulin sensitivity and control diabetes, then treatment can be effective, but patient compliance becomes difficult

Engineering Contradiction:
Improvetreatment efficacyVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent develops a polysaccharide supplement that can be administered orally without requiring patients to change their lifestyle habits. The H. sinensis polysaccharide works independently to improve insulin sensitivity and control blood glucose levels, allowing the body to benefit from the treatment without requiring patient effort in lifestyle modification, thus resolving the contradiction between efficacy and compliance

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If alternative measures are introduced in the diet to prevent diabetes, then treatment can avoid severe toxicity, but the measures may require important lifestyle changes

Engineering Contradiction:
ImprovetoxicityVSAvoidlifestyle changes
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The patent extracts the specific polysaccharide component from H. sinensis mycelium, creating a targeted supplement that provides protective effects against diabetes without requiring comprehensive lifestyle changes. This extraction allows introducing a single dietary element rather than requiring multiple lifestyle modifications, resolving the contradiction between reduced toxicity and ease of implementation

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polysaccharide effectively reduces hyperglycemia and improves insulin sensitivity in humans and animals, offering a potential treatment or preventive measure for type 2 diabetes and related disorders without significant lifestyle changes or adverse effects.

Implementation Method 1

improving insulin sensitivity by using a polysaccharide isolated from Hirsutella sinensis

Methodology Applied
Scientific EffectInsulin signaling:

Implementation Method 2

The H. sinensis polysaccharide reduces blood insulin and blood glucose levels in a subject

Methodology Applied
Scientific EffectGlucose transport:

Data Source

PatentUS9828442B2Method to prepare <i>Hirsutella sinensis </i>polysaccharides possessing insulin-sensitizing properties and applications thereof
Publication Date: 2017.11.28 CHANG GUNG BIOTECH
  • US9828442B2 patent drawing
  • US9828442B2 patent drawing
  • US9828442B2 patent drawing

AI summary

The present invention provides a method to prepare polysaccharides from Hirsutella sinensis. The prepared polysaccharides can reduce hyperglycemia and insulin resistance, and can therefore be used to prevent and treat type 2 diabetes and related conditions.